PG
Procter&Gamble (PG)
NYSE
$144.74+$0.06 (+0.04%)
Price as of Aug 21, 2026 7:59 PM EDT
  • $336.3B
    Market Cap
  • -6.14%
    1-Year Change
  • Household & Personal Products
    Industry

Key Performance

More
  • Earnings Score: 62
  • Momentum Score: 21
  • True Yield: 78
  • Financial Health Score: 49
TradeSmith Loading

Latest Research & News

This Under-the-Radar Healthcare Stock Yields Nearly 8.5%. Here's Whether That Income Is Too Good to Be True.

Perrigo, a generic over-the-counter drug manufacturer, offers an attractive 8.3% dividend yield, but the article warns investors to be cautious. The company faces declining sales (down 3.1% YoY), weakening margins, and leadership uncertainty following the CEO's abrupt departure. While the dividend appears covered for now, risks include a shrinking business, potential asset sales, and the possibility of dividend cuts under new management.

08/22/2026, 5:15 PMThe Motley Fool

The Best Dividend Stock for 2027 and Beyond: Procter & Gamble

Procter & Gamble is highlighted as an ideal dividend stock for 2027 and beyond, offering a 3% yield with consistent 4-6% annual dividend growth that has historically outpaced inflation. With 70 consecutive years of dividend increases, strong cash flow generation ($19.6B in fiscal 2026), and resilient consumer brands, P&G provides stable income and purchasing power protection in an uncertain market environment with rising bond yields and stretched valuations.

08/21/2026, 7:15 AMThe Motley Fool

No Matter What Happens to the Market, These 3 Dividend Stocks Belong in Your Portfolio

The article recommends three consumer staples dividend stocks—Procter & Gamble, Coca-Cola, and PepsiCo—as reliable portfolio anchors during market volatility. All three companies have decades-long histories of consistent dividend payments and annual increases, selling everyday essential products that maintain demand regardless of economic conditions.

08/18/2026, 6:30 AMThe Motley Fool

Is iShares US Consumer Staples ETF a Better Buy Than Invesco Food & Beverage?

The iShares U.S. Consumer Staples ETF (IYK) outperforms the Invesco Food & Beverage ETF (PBJ) across multiple metrics, including a lower 0.38% expense ratio versus 0.61%, higher 2.6% dividend yield versus 1.3%, and superior 1-year returns of 8.9% versus -1.0%. With 53 diversified holdings across consumer staples, healthcare, and materials versus PBJ's 31 food and beverage-focused companies, IYK offers broader sector exposure and better long-term performance.

08/11/2026, 3:29 PMThe Motley Fool

The Dow Is Outperforming the S&P 500 and Nasdaq in 2026. 3 Unstoppable Dow Stocks to Buy in August.

The Dow is outperforming the S&P 500 and Nasdaq in 2026 due to large consumer-facing companies delivering steady earnings and dividends. Three recommended Dow stocks for August are Procter & Gamble, McDonald's, and Home Depot—all established companies with resilient business models, strong cash generation, and consistent shareholder returns despite economic headwinds.

08/11/2026, 5:30 AMThe Motley Fool

Looking to Generate Passive Income From Stocks? 3 Unstoppable Dividend Stocks to Buy Now.

The article recommends three consumer-facing dividend stocks for passive income: Procter & Gamble (70 years of consecutive dividend increases), McDonald's (49 years of raises with 7-8% annual growth), and Coca-Cola (50+ years of dividend increases). All three offer modest yields (2.4-2.9%) but provide reliable, growing dividends backed by resilient businesses and strong cash flow generation, making them suitable for long-term income investors.

08/10/2026, 7:30 AMThe Motley Fool

I've Been Writing About Procter & Gamble Stock for Years. Here's Why My Conviction Has Never Been Higher.

A Motley Fool analyst expresses increased conviction in Procter & Gamble, highlighting the company's consistent execution of fundamentals including modest organic growth, innovation, disciplined cost management, and strong shareholder returns. Despite modest fiscal 2026 results (3% net sales growth, 1% organic growth), P&G delivered within guidance while navigating currency headwinds and cost pressures. The company's 70-year dividend growth streak, integration of AI-driven tools, and e-commerce expansion (now 20% of sales) demonstrate durability and modernization of its business model.

08/10/2026, 5:15 AMThe Motley Fool

Why the "Magnificent Seven" Trade Is Starting to Fracture, and Where You Should Invest Instead

The article argues that the Magnificent Seven tech stocks (Alphabet, Amazon, Apple, Meta, Microsoft, Nvidia, Tesla) are destined to fracture as investor exuberance pushes valuations beyond fundamental value, similar to historical bubbles like the Nifty 50. The author recommends diversifying into consumer staples like Procter & Gamble and Coca-Cola, which offer stable dividends, reasonable valuations, and resilience through market cycles.

08/04/2026, 8:15 AMThe Motley Fool

P&G Guided Below Estimates and Sits 5% Above a 52-Week Low. I'm Not Buying It Yet, and Here's What Would Change That.

Procter & Gamble issued fiscal 2027 guidance implying less than 2% core earnings per share growth, weighed down by $1.36 billion in expected headwinds from commodity costs, energy, transportation, and interest expenses. The company's organic sales growth has decelerated to flat in the latest quarter, driven entirely by pricing rather than volume growth. While the stock yields 3% near its 52-week low, the analyst remains cautious, waiting for evidence of volume recovery or a lower entry price around $130 before investing.

08/03/2026, 5:09 AMThe Motley Fool

Procter & Gamble Stock: Buy, Hold, or Sell?

Procter & Gamble is highlighted as one of the better-managed companies in the world. The article suggests that near-term headwinds could present an excellent opportunity to accumulate PG stock. The company is noted for being a Dividend King with 70 consecutive years of dividend increases.

07/31/2026, 11:18 PMThe Motley Fool

Which Consumer Staples ETF Is the Better Buy: Fidelity's FSTA or iShares' IYK?

Fidelity's FSTA ETF offers a significantly lower expense ratio of 0.08% compared to iShares' IYK at 0.38%, while delivering stronger five-year returns ($1,401 vs $1,370 on $1,000 invested). FSTA holds 104 stocks with pure consumer staples focus, whereas IYK holds 53 stocks with broader diversification including healthcare and basic materials. For most long-term investors, FSTA's lower costs and better performance make it the more practical choice, though IYK appeals to those seeking higher dividend yield (2.5% vs 2.2%) and sector diversification.

07/31/2026, 10:01 AMThe Motley Fool

Prediction: This Dividend ETF Will Thrive After 20 Years No Matter What the Market Does

The Schwab U.S. Dividend Equity ETF (SCHD) is recommended as the best dividend ETF for long-term investors seeking a 20-year income strategy. Unlike the Vanguard Dividend Appreciation ETF (VIG) and iShares Core Dividend Growth ETF (DGRO), SCHD maintains better sector balance and prioritizes dividend yield and fundamental value, with top holdings in stable consumer staples like Coca-Cola, Merck, Chevron, and Procter & Gamble that will remain relevant over decades.

07/28/2026, 6:30 AMThe Motley Fool

VDC vs. FTXG: Which Defensive ETF Is the Better Buy?

Vanguard's VDC and First Trust's FTXG are both defensive ETFs investing in consumer staples, but with different approaches. VDC offers broader diversification across 103 stocks with a lower 0.09% expense ratio and stronger 5-year returns, while FTXG concentrates on 30 food and beverage companies with a higher 2.59% dividend yield but higher 0.60% expense ratio. For most long-term investors, VDC is the more straightforward choice due to lower costs and better diversification.

07/28/2026, 6:28 AMThe Motley Fool

1 Reason to Buy This Dividend King Stock Before It Reports Earnings on July 29

Procter & Gamble, a Dividend King with 71 consecutive years of dividend increases, offers defensive portfolio diversification as an alternative to the AI and tech-heavy investments dominating retail investor portfolios. With a 2.91% dividend yield and a history of beating Wall Street estimates, P&G provides stable income and lower volatility ahead of its July 29 earnings report.

07/27/2026, 1:05 PMThe Motley Fool

Should You Buy Procter & Gamble Stock Before July 29?

Procter & Gamble faces headwinds ahead of its July 29 earnings release, including higher commodity costs, tariffs, and interest rates. The company expects fiscal 2026 EPS toward the lower end of guidance. With stock down 7% over the past year versus S&P 500 up 16%, investors may want to wait for full-year results and fiscal 2027 guidance before buying, though the 2.9% dividend yield appeals to long-term income investors.

07/26/2026, 11:15 AMThe Motley Fool

Peers

Statistics

More
Day Range
$142.14
$145.27
$144.68
1-Year Range
$138.04
$167.20
$144.68
Latest Close$144.68
Change
+$1.71 (+1.18%)
Volume10,272,129
Market Cap$336.3B
Shares Outstanding2.3B
P/E (TTM)21.84
Diluted EPS (TTM)$6.62
Enterprise Value$360.5B

Information as of 08/21/2026

Company Profile

PROCTER & GAMBLE CO
PROCTER & GAMBLE CO
https://www.pginvestor.com
$336.3B
Market Cap
$16.0B
Net Income
Sector: Consumer Defensive
Industry: Household & Personal Products
One Procter & Gamble Plaza, Cincinnati, OH, United States, 45202
513 983 1100

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The company offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; antiperspirants, deodorants, and personal cleansing products under the Native, Old Spice, Safeguard, and Secret brands; and facial moisturizers, cleaners, and treatments under the Olay and SK-II brands. It also provides blades, razors, shave products, appliances, and other grooming products under the Braun, Gillette, and Venus brands. In addition, the company offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brands; and gastrointestinal, pain relief, rapid diagnostics, respiratory, vitamins/minerals/supplements, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. Further, it provides fabric enhancers, and laundry additives and detergents under the Ariel, Downy, Gain, and Tide brands; and air and dish care, P&G professional, and surface care under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. Additionally, the company offers baby wipes, taped diapers, and pants under the Luvs and Pampers brands; adult incontinence and menstrual care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. It sells its products through mass merchandisers, social ecommerce channels, grocery and specialty beauty stores, membership club stores, drug and department stores, distributors, wholesalers, airport duty-free and high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The company was founded in 1837 and is headquartered in Cincinnati, Ohio.

Key Executives

  • Jon R. Moeller
  • Balaji Purushothaman
  • Sundar G. Raman
  • Shailesh G. Jejurikar
  • Andre Schulten

Current Ownership Distribution

  • Institutions29.3B (77.28%)
  • Mutual Funds8.6B (22.69%)
  • Insiders11.3M (0.03%)
  • Other0 (0.00%)